Literature DB >> 15560713

Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.

Meng Law1, Micole Hamburger, Glyn Johnson, Matilde Inglese, Ana Londono, John Golfinos, David Zagzag, Edmond A Knopp.   

Abstract

Advanced MRI techniques, such as MR spectroscopy, diffusion and perfusion MR imaging can give important in vivo physiological and metabolic information, complementing morphologic findings from conventional MRI in the clinical setting. Combining perfusion MRI and MR spectroscopy can help in patients with brain masses in who the pre-operative differential diagnosis is unclear. This review demonstrates the use of dynamic, susceptibility weighted, contrast-enhanced MR imaging (DSC MRI) and magnetic resonance spectroscopic imaging (MRSI) to distinguish surgical from non-surgical lesions in the brain. There is overlap in the MRI appearance of many enhancing and ring-enhancing lesions such as gliomas, metastases, inflammatory lesions, demyelinating lesions, subacute ischemia, abscess and some AIDS related lesions. We review examples of histopathologically confirmed high-grade glioma, a middle cerebral artery territory infarct, a tumefactive demyelinating lesion and a metastasis for which conventional MR imaging (MRI) was non-specific and potentially misleading and demonstrate how DSC MRI and MRSI features were used to increase the specificity of neurodiagnosis. At several institutions, many patients routinely undergo MRI as well as MRSI and DSC MRI. Cerebral blood flow (CBF), mean transit time (MTT), and relative cerebral blood volume (rCBV) measurements are obtained from regions of maximal perfusion as determined from perfusion color overlay maps. Metabolite levels and ratios are determined for Choline (Cho), N-Acetyl Aspartate (NAA), Lactate and Lipids (LL). Metabolite levels are obtained by measuring the peak heights of each metabolite and the ratios are obtained from these measurements for Cho/Cr, Cho/NAA and NAA/Cr. Neurosurgical intervention carries substantial morbidity, mortality, financial and potential emotional cost to the patient and family. Making a pre-operative diagnosis allows the neurosurgeon to be confident in the choice of treatment plan for the patient and allays considerable patient anxiety. The utility of combining clinical findings with multi-parametric information from perfusion and spectroscopic MR imaging in differentiating surgical lesions from those which do not require surgical intervention is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15560713     DOI: 10.1177/153303460400300605

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  12 in total

1.  Hyperpolarized water as an authentic magnetic resonance imaging contrast agent.

Authors:  Evan R McCarney; Brandon D Armstrong; Mark D Lingwood; Songi Han
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

2.  Case 11: a young woman with ring-enhancing brain lesions.

Authors:  Irene Cortese; Avindra Nath
Journal:  MedGenMed       Date:  2006-01-05

3.  Perfusion MR imaging and proton MR spectroscopic imaging in differentiating necrotizing cerebritis from glioblastoma multiforme.

Authors:  Gabriel Pivawer; Meng Law; David Zagzag
Journal:  Magn Reson Imaging       Date:  2006-11-20       Impact factor: 2.546

4.  Proton MRS imaging in pediatric brain tumors.

Authors:  Maria Zarifi; A Aria Tzika
Journal:  Pediatr Radiol       Date:  2016-05-27

Review 5.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

6.  In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck.

Authors:  Sotirios Bisdas; Mehran Baghi; Frank Huebner; Cindy Mueller; Rainald Knecht; Marianne Vorbuchner; Jan Ruff; Wolfgang Gstoettner; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-05-16       Impact factor: 5.315

7.  Impact of adjuvant chemotherapy for gliomatosis cerebri.

Authors:  Doo-Sik Kong; Sung Tae Kim; Jung-Il Lee; Yeon-Lim Suh; Do Hoon Lim; Won Seog Kim; Ki-Hoon Kwon; Kwan Park; Jong Hyun Kim; Do-Hyun Nam
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

Review 8.  Quantitative imaging biomarkers in neuro-oncology.

Authors:  Adam D Waldman; Alan Jackson; Stephen J Price; Christopher A Clark; Thomas C Booth; Dorothee P Auer; Paul S Tofts; David J Collins; Martin O Leach; Jeremy H Rees
Journal:  Nat Rev Clin Oncol       Date:  2009-06-23       Impact factor: 66.675

9.  Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?

Authors:  R Hourani; L J Brant; T Rizk; J D Weingart; P B Barker; A Horská
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-30       Impact factor: 3.825

Review 10.  Advanced imaging techniques in brain tumors.

Authors:  Meng Law
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.